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Addition of ATP (but not epinephrine, angiotensin II, vasopressin, or platelet-activating factor) to H-35 
hepatoma cells whose cellular lipids have been pre-labelled with [3H]inositol, causes a rapid increase in 
[3H]inositol trisphosphate. In H-35 cells pre-incubated in the presence of 45CaZ+, ATP causes a similarly 
rapid release of 4sCaZ+. The concentration-effect relationships for inositol trisphosphate formation and Caz+ 
efflux are similar to those reported previously for differentiated hepatocytes. These results demonstrate that 
at least one of the Caz+-mobilizing receptors normally found on hepatocytes i  functionally retained in the 
H-35 hepatoma cell line and thus could provide a useful model for the study of these receptor mechanisms 
in liver. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Well characterized immortal tumor cell lines 2.1. Cell culture 
have proven useful experimental tools in a wide 
variety of areas of cell biology. This is especially 
true for tumor lines which retain certain differen- 
tiated functions of the parent tissue, and can thus 
be studied under controlled or manipulated en- 
vironmental conditions. To date, no studies have 
been reported on the actions of Ca2+-mobilizing 
receptors in liver tumor (hepatoma) cell lines, 
presumably because the more conventional recep- 
tors (vasopressin, ai-adrenergic) have been lost 
following transformation of these cells. Here we 
report that one such receptor mechanism, the 
Pz-purinergic receptor mechanism, is apparently 
retained in the H-35 Reuber hepatoma cell line, as 
evidenced by the ability of micromolar concentra- 
tions of ATP to activate inositol trisphosphate 
(IP3) formation and to stimulate 45Ca2+ efflux. 
The Pz receptor mechanism in the H-35 cell line 
may thus prove to be a useful experimental system 
for probing the mechanisms of Ca’+-mobilizing 
receptors in the liver. 
H-35 hepatoma cells were generously provided 
by M. Czech, University of Massachusetts, and 
were grown and maintained in T-75 culture flasks 
in Dulbecco’s Minimal Essential Medium 
(DMEM) containing 10% fetal bovine serum 
(FBS) with 5% CO2 in air at 37°C. Prior to ex- 
periments cells were transferred to 60 x 15 mm 
plastic petri dishes at a concentration of 6 x ld 
cells per ml in 3 ml of DMEM containing 10% 
FBS. After 2 or 3 days the medium was aspirated 
and replaced with DMEM containing no serum. 
After 48 h, the medium was removed, and, in in- 
ositol phosphate experiments, 20 ,&i [3H]inositol 
in 2 ml DMEM was added. The [3H]inositol la- 
beled cells were used in experiments after 40 h of 
further incubation. 
2.2. Determination of PHJinositolphosphates and 
[3Hlnositol lipids 
At the end of the 40 h labeling period, the cells 
were washed twice with sterile Puck’s saline and in- 
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cubated for 1 h in 2 ml serum free DMEM. ATP 
was added in varying concentrations by aspirating 
the DMEM and replacing with 1 ml DMEM con- 
taining ATP. The reaction was quenched at 
various times by the addition of 2 ml of 4.5% per- 
chloric acid. The dishes were left on ice for at least 
20 min to extract the water soluble inositol 
phosphates. The perchlorate in the supernatant 
was precipitated with ice cold KOH and sodium 
tetraborate buffer (3 ml), vortex-mixed and cen- 
trifuged as described [l]. The neutralized superna- 
tant was then applied to a Dowex anion exchange 
column, and inositol phosphates were eluted with 
increasing concentrations of ammonium formate 
as described previously. When isomers of IP3 were 
to be determined [3zP](1,4,5)IP3, prepared from 
red cell membranes [2], was added along with the 
perchloric acid. In these experiments, the superna- 
tant was added to 3.3 ml of freon/octylamine 
(1: 1) [3]. The tubes were vortex-mixed vigorously 
and centrifuged at 2400 rpm for 3 min. The top 
layer containing the inositol phosphates was 
removed and applied directly to an HPLC column 
to determine IP3 isomer proportions as described 
PI. 
In both inositol phosphate and isomer ex- 
periments, total acid insoluble radioactivity 
(presumably [3H]phosphoinositides) was removed 
from the dishes with 2 ml of 1 N NaOH, aided by 
scraping with a rubber policeman. Inositol 
phosphate data are expressed as a percentage of 
the radioactivity in this fraction. 
2.3. 4sCd’ efflux from H-35 cells 
H-35 cells were cultured to confluent 
monolayers as described above for determination 
of inositol phosphates and phosphoinositides. 
Following incubation in serum free DMEM for 
48 h the cells were incubated with 10,&i 45CaC12 
in 2 ml of serum free DMEM for 40 h. The 
medium was replaced 3 times with 2 ml serum free 
DMEM at 10 min intervals. After 30 min the 
medium was aspirated and immediately replaced at 
30 s intervals, for a total of 10 min. ATP was pre- 
sent in the medium between 5 and 10 min of in- 
cubation. The aspirated medium was added to 
10 ml of scintillant and counted for radioactivity. 
At the end of the 10 min incubation, cells were 
removed from the dish by addition of 2 ml tryp- 
sin/EDTA and the total 45Ca2+ remaining in the 
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cells was determined. Apparent first-order rate 
coefficients for 45Ca2+ efflux were calculated as 
described [4]. 
3. RESULTS 
ATP (3OOpM) induced a rapid increase in the 
rate of 4sCa2+ efflux from H-35 cells (fig.1); the 
response was maximal within 30 s, and had re- 
turned to basal levels 3 min after the initial ap- 
plication of ATP, despite the replenishment of 
medium with fresh ATP every 30 s with this pro- 
tocol. The transienee of this response presumably 
reflects the finite size of the ATP-sensitive Ca2+ 
pool which would appear to be about 15-20% of 
exchangeable Ca2+. This value is comparable to 
the size of the hormone-sensitive pool in 
hepatocytes [5]. 
Fig.2 demonstrates that ATP (lOO/rM) induced 
a rapid increase in cellular levels of [‘H]IP, and 
[3H]IP2 in H-35 cells. Levels of [3H]IPs were max- 
imally increased in 30 s, which could be rapid 
enough to mediate the 4sCa2+ release. The [‘H]IPs 
was separated from other inositol phosphates by 
the technique of Berridge et al. [6], and thus could 
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Fig. 1. Efflux of 45CaZ+ from H-35 hepatoma cells. Cells 
pre-equilibrated with 45Ca2+ for 40 h were incubated 
sequentially in non-radioactive medium for 30 s 
intervals for 10 min. as described in section 2. ATP 
(3OOrM) was present from 5 to 10 min. One of three 
experiments, each similar in result, is shown. 
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Fig.2. Time course of increase in [3H]inositol 
phosphates in H-35 hepatoma cells. Cellular lipids were 
pre-labeled with [3H]inositol as described in section 2. 
1OOpM ATP was added to dishes of cells, which were 
perchloric acid quenched after 30, 60 or 120 s and 
analyzed for [3H]IP3 ( M) and [‘H]IPz (m) as 
described [ 1,6]. The value at t = 0 indicates cells prior to 
stimulation. The data are expressed as % of total acid 
insoluble radioactivity (primarily [3H]phosphoinositi- 
des, [3H]PI). Means f SE of three experiments. 
contain both or either of the two isomers of IPs 
along with some [3H]IP4 [7]. Samples taken from 
unstimulated cells (n = 2) and from cells after 30 s 
stimulation with 300 M ATP (n = 3) were analyzed 
by HPLC. There was no detectable [3H]IP4 in 
either control or stimulated cells. Control cells 
contained [3H](l,4,5)IPs (0.098, 0.064 %PI) but 
no detectable [3H](1,3,4)IP~. On stimulation 
[3H] 1,4,5)IP3 levels were increased more than 
6 3-fo (0.353 f 0.063 VoPI), and a roughly 
equivalent amount of [3H](1,3,4)IP3 was formed 
(0.290 + 0.019 VOPI). 
Fig.3 summarizes concentration-effect data for 
ATP-induced 45Ca2+ efflux. The values were 
calculated as the net increase in rate coefficient in 
the first 30 s interval after ATP addition. A 
substantial (about 2-fold) increase in efflux was 
detected with 3 pM ATP; maximal and half- 
maximal responses were obtained with 100 and 
10 FM concentrations, respectively. 
Concentration-effect data were also obtained 
for inositol phosphate generation, again using the 
value obtained at 30 s after addition of ATP 
14 r 
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Fig.3. Concentration-effect relationship for ATP- 
induced 4sCa2+ efflux. The protocol was as for fig.1. 
The basal efflux just prior to ATP addition was 
subtracted from the maximal increase obtained at 30 s 
after ATP addition. Means + SE of three experiments. 
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Fig.4. Concentration-effect relationship for ATP- 
induced formation of [3H]IP3 ( M) and [3H]IP2 
(M). The protocol was as for fig.2, except that the 
perchloric acid was added 30 s after the indicated 
concentration of ATP. Means k SE of four experiments. 
(fig.4). Somewhat higher concentrations of ATP 
were required for generation of [‘H]IP3, with a 
half-maximal increase occurring at about 30pM, 
and a maximal increase at 300 FM. 
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4. DISCUSSION 
The first report of agonist effects of exogenous 
ATP on the liver was by Jenkinson and Koller [8] 
who found that ATP hyperpolarized cells of 
guinea-pig liver slices in a manner similar to cy- 
adrenoceptor agonists. Subsequent studies in a 
number of laboratories demonstrated that ATP 
produces biochemical effects in the liver which are 
mechanistically indistinguishable from the more 
extensively investigated a-adrenoceptor or peptide 
receptor effects [9-l 11. Since the putative receptor 
mediating these effects prefers ATP to adenosine, 
it would be characterized as a P2-type purinergic 
receptor [ 121. 
In preliminary studies on the effects of various 
agonists on the formation of [‘H]IPs, ATP pro- 
duced a significant increase in the level of this 
putative mediator; negative results were obtained 
with phenylephrine (10 PM), angiotensin II 
(1 PM), vasopressin (1 pM), and platelet activating 
factor (10 nM). The reason why, as a result of 
transformation, all but one of the Ca2+ and 
phosphoinositide-linked receptors normally pre- 
sent on hepatocytes are no longer expressed is not 
known. However, the ATP mechanism appears to 
be functionally intact. ATP caused a rapid increase 
in cellular [‘H]IP3, and the concentration-effect 
relationship (fig.4) was similar to that reported for 
rat hepatocytes by Charest et al. [ 111. Also in 
agreement with Charest et al. [ll], the curve for 
Ca’+-mobilization (fig.3) appears to lie somewhat 
to the left (lower ATP concentrations) of that for 
IP3 production, a finding consistent with the idea 
that IP3 formation may precede Ca2+ mobilization 
in the stimulus-response coupling pathway in the 
H-35 cells, as previously suggested for the 
hepatocyte [13,14]. Thus, the Pz-type ATP recep- 
tor mechanism in the H-35 hepatoma cell line may 
be a useful model system for understanding the 
properties and regulation of Ca2+ and 
phosphoinositide-linked receptors in the liver. 
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